Nanomi Receives CMO Award for Life Science Leadership in Drug Delivery USA - English USA - English

~ Nanomi B.V., a Dutch subsidiary of the global pharmaceutical company Lupin Limited, has been honored with the prestigious CMO Award for Life Science Leadership in Drug Delivery. The award was presented during the Drug, Chemical and Associated Technologies Association (DCAT) week in New York.

Nanomi's innovative approach to drug delivery has set new standards in the industry, making them a leader in the field. This recognition serves as a testament to their commitment to revolutionizing healthcare.

Dr. Shahin Fesharaki, Global Chief Scientific Officer at Lupin, expressed his excitement about the award, stating that it highlights Nanomi's dedication to advancing science and their pioneering efforts in drug delivery. He also emphasized their continued commitment to innovation in order to provide high-quality medicines that greatly improve patient outcomes.

More on EntSun News

• DecisionPoint Technologies Accelerates Growth with Acquisition of Acuity Technologies
• CCHR: Involuntary Commitment Is Eugenics Repackaged as "Mental Health Care"
• Q2 2025 Industry Impact Report Underscores Semiconductor Expansion, Talent Development and Sustainability Milestones
• 84 Ethiopian Churches Change Signboards to Shincheonji Church of Jesus
• BTXSGG Outlines Four-Pillar Framework to Enhance Digital Asset Security and Compliance

The CMO Leadership Awards were established in 2011 and are presented by Outsourced Pharma and Life Science Connect with research conducted by Orientation Marketing. They recognize top outsourcing partners based on feedback from sponsor companies who outsource manufacturing. This year marks the first time that the CMO Leadership Award is being juried.

Nanomi's achievement is a testament to their dedication and hard work in pushing boundaries and setting new standards in drug delivery. Their innovative approach has not only earned them this prestigious award but also serves as motivation for them to continue their mission of revolutionizing healthcare.

---

Show All News | Report Violation